{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:33:38Z","timestamp":1648697618875},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T00:00:00Z","timestamp":1202256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00296-008-0535-6","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T08:25:33Z","timestamp":1202199933000},"page":"851-857","source":"Crossref","is-referenced-by-count":3,"title":["Serum IgG activity against cyclic citrullinated peptide in patients evaluated for rheumatoid factor correlates with the IgM isotype"],"prefix":"10.1007","volume":"28","author":[{"given":"M. G.","family":"Zavala-Cerna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Garc\u00eda-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dur\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Arias-Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Salazar-P\u00e1ramo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,6]]},"reference":[{"key":"535_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","volume":"4","author":"MA Boekel van","year":"2002","unstructured":"van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res Ther 4:87\u201393","journal-title":"Arthritis Res Ther"},{"key":"535_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"535_CR3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25:1106\u20131118","journal-title":"Bioessays"},{"key":"535_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbrc.2005.05.137","volume":"333","author":"A Suzuki","year":"2005","unstructured":"Suzuki A, Yamada R, Ohtake-Yamanaka M, Okazaki Y, Sawada T, Yamamoto K (2005) Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 333:418\u2013426","journal-title":"Biochem Biophys Res Commun"},{"key":"535_CR5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2004.02708.x","volume":"139","author":"S Chapuy-Regaud","year":"2005","unstructured":"Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G (2005) IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol 139:542\u2013550","journal-title":"Clin Exp Immunol"},{"key":"535_CR6","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","volume":"7","author":"A Kinloch","year":"2005","unstructured":"Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, Moyes D, Taylor PC, Venables PJ (2005) Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 7:R1421\u2013R1429","journal-title":"Arthritis Res Ther"},{"key":"535_CR7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","volume":"62","author":"DM Lee","year":"2003","unstructured":"Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62:870\u2013874","journal-title":"Ann Rheum Dis"},{"key":"535_CR8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","volume":"63","author":"I Vallbracht","year":"2004","unstructured":"Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079\u20131084","journal-title":"Ann Rheum Dis"},{"key":"535_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"},{"key":"535_CR10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"VP Nell","year":"2005","unstructured":"Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731\u20131736","journal-title":"Ann Rheum Dis"},{"key":"535_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","volume":"64","author":"L Rycke De","year":"2005","unstructured":"De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F (2005) Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. Ann Rheum Dis 64:299\u2013302","journal-title":"Ann Rheum Dis"},{"key":"535_CR12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA Gaalen van","year":"2004","unstructured":"van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50:709\u2013715","journal-title":"Arthritis Rheum"},{"key":"535_CR13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797\u2013808","journal-title":"Ann Intern Med"},{"key":"535_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357\u2013365","journal-title":"Arthritis Rheum"},{"key":"535_CR15","first-page":"2115","volume":"33","author":"JA Hill","year":"2006","unstructured":"Hill JA, Al-Bishri J, Gladman DD, Cairns E, Bell DA (2006) Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis. J Rheumatol 33:2115\u20132119","journal-title":"J Rheumatol"},{"key":"535_CR16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1196\/annals.1313.033","volume":"1050","author":"U Sauerland","year":"2005","unstructured":"Sauerland U, Becker H, Seidel M, Schotte H, Willeke P, Schorat A, Schluter B, Domschke W, Gaubitz M (2005) Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci 1050:314\u2013318","journal-title":"Ann N Y Acad Sci"},{"key":"535_CR17","first-page":"2074","volume":"29","author":"AL Jansen","year":"2002","unstructured":"Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29:2074\u20132076","journal-title":"J Rheumatol"},{"key":"535_CR18","first-page":"2390","volume":"33","author":"T Matsui","year":"2006","unstructured":"Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S (2006) Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 33:2390\u20132397","journal-title":"J Rheumatol"},{"key":"535_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/ar1184","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, van Venrooij WJ (2004) Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 6:107\u2013111","journal-title":"Arthritis Res Ther"},{"key":"535_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00726-005-0235-4","volume":"29","author":"E Curis","year":"2005","unstructured":"Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, Cynober L (2005) Almost all about citrulline in mammals. Amino Acids 29:177\u2013205","journal-title":"Amino Acids"},{"key":"535_CR21","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","volume":"50","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485\u20133494","journal-title":"Arthritis Rheum"},{"key":"535_CR22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01171.x","volume":"119","author":"C Masson-Bessiere","year":"2000","unstructured":"Masson-Bessiere C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, Durroux R, Cantagrel A, Serre G (2000) In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 119:544\u2013552","journal-title":"Clin Exp Immunol"},{"key":"535_CR23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","volume":"171","author":"JA Hill","year":"2003","unstructured":"Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171:538\u2013541","journal-title":"J Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0535-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-008-0535-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0535-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:16:10Z","timestamp":1559042170000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-008-0535-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,6]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1007\/s00296-008-0535-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,6]]}}}